T Cell Determinants Incorporating β-Amino Acid Residues Are Protease Resistant and Remain Immunogenic In Vivo
Open Access
- 15 September 2005
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 175 (6) , 3810-3818
Abstract
A major hurdle in designing successful epitope-based vaccines resides in the delivery, stability, and immunogenicity of the peptide immunogen. The short-lived nature of unmodified peptide-based vaccines in vivo limits their therapeutic application in the immunotherapy of cancers and chronic viral infections as well as their use in generating prophylactic immunity. The incorporation of β-amino acids into peptides decreases proteolysis, yet its potential application in the rational design of T cell mimotopes is poorly understood. To address this, we have replaced each residue of the SIINFEKL epitope individually with the corresponding β-amino acid and examined the resultant efficacy of these mimotopes. Some analogs displayed similar MHC binding and superior protease stability compared with the native epitope. Importantly, these analogs were able to generate cross-reactive CTLs in vivo that were capable of lysing tumor cells that expressed the unmodified epitope as a surrogate tumor Ag. Structural analysis of peptides in which anchor residues were substituted with β-amino acids revealed the basis for enhanced MHC binding and retention of immunogenicity observed for these analogs and paves the way for future vaccine design using β-amino acids. We conclude that the rational incorporation of β-amino acids into T cell determinants is a powerful alternative to the traditional homologous substitution of randomly chosen naturally occurring α-amino acids, and these mimotopes may prove particularly useful for inclusion in epitope-based vaccines.Keywords
This publication has 33 references indexed in Scilit:
- Functional and Structural Characteristics of NY-ESO-1-related HLA A2-restricted Epitopes and the Design of a Novel Immunogenic AnalogueJournal of Biological Chemistry, 2004
- Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine designJournal of Peptide Science, 2003
- β-Amino Acid Scan of a Class I Major Histocompatibility Complex-restricted Alloreactive T-cell EpitopeJournal of Biological Chemistry, 2001
- Melanoma Peptide MART-1(27−35) Analogues with Enhanced Binding Capacity to the Human Class I Histocompatibility Molecule HLA-A2 by Introduction of a β-Amino Acid Residue: Implications for Recognition by Tumor-Infiltrating LymphocytesJournal of Medicinal Chemistry, 2000
- Immunoglobulin β Signaling Regulates Locus Accessibility for Ordered Immunoglobulin Gene RearrangementsJournal of Experimental Medicine, 2000
- Serum stability of phosphopeptidesAnalytica Chimica Acta, 1997
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Improved methods for building protein models in electron density maps and the location of errors in these modelsActa Crystallographica Section A Foundations of Crystallography, 1991
- The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb‐restricted ovalbumin determinantEuropean Journal of Immunology, 1990
- Empty MHC class I molecules come out in the coldNature, 1990